-
Bharti Airtel
1,936.05 1,745.00(%) -
Bluestone Jewel
832.00 872.60(%) -
Gandhar Oil Ref.
283.85 245.00(%) -
Oracle Fin.Serv.
11,394.75 11,986.90(%) -
Dr Reddy's Labs
1,080.05 1,149.00(%) -
SBI Funds Mgt.
575.35 582.55(%) -
Eternal
291.30 368.40(%) -
Kalyan Jewellers
602.00 617.30(%) -
Tanla Platforms
625.45 765.75(%) -
Nippon ETF Liq.
1,000.01 1,010.50(%) -
Data Pattern
4,672.60 2,131.00(%) -
Adani Green
1,403.00 767.00(%) -
Millworks Technologies
727.95 693.30(%) -
H P C L
376.80 316.20(%) -
HDFC Bank
746.00 726.75(%) -
Cupid
211.00 225.90(%) -
Wakefit Innovati
147.95 223.95(%) -
Dixon Technolog.
13,971.95 18,471.50(%) -
Reliance Industries
1,277.85 1,253.65(%) -
Uflex
515.00 609.95(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Indoco Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 12579.0
- ISIN : INE873D01024
-
Today’s Low
232.60 -
Today’s High
246.00
-
Open
245.25 -
Perv Close
245.84 -
52W Low
162.19 -
52W High
336.00
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
2,152.52
-
Div & Yield %
0.09
-
Book Value(₹)
119.08
-
Debt-Equity Ratio
-5.14
-
AGM Date
22-Jul-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
0.47
-
Mar.Cap (₹Cr.)
2,152.52
-
RONW (%)
9.07
-
ROCE (%)
10.76
Score Board
-
Equity (₹ in Cr.)
18.46
-
BV (₹)
119.10
-
Sales( ₹ in Cr.)
1,633.54
-
NP (in Cr.)
-3.53
-
NP Var(%)
64.0
-
Div%
10.0
-
CPS (₹)
11.20
-
EPS (₹)
-0.40
-
Traded Value (₹ in Lakhs)
2,154.37
-
52 Week High
336.00
-
52 Week Low
162.19
-
Price BSE
233.0
-
Price NSE
233.00
-
Market Capital( in Cr.)
2,154.37
-
P/C Ratio
20.80
-
P/E Ratio
-609.60
-
Price Vs.BV
-0.40
-
16-Jul-2026( 10:17)
Corporate News - Indoc... - Indoco Remedies will hold a me...
-
26-Jun-2026( 12:31)
Corporate News - Indoc... - Indoco Remedies announced that...
-
29-May-2026( 12:25)
Hot Pursuit - Indoc... - The facility was inspected bet...
-
14-May-2026( 11:20)
Corporate News - Indoc... - Indoco Remedies has announced...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 1,518.19 | 1,790.81 | 1,666.69 | 1,539.72 | 1,240.30 | 1,105.99 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,518.19 | 1,790.81 | 1,666.69 | 1,539.72 | 1,240.30 | 1,105.99 |
| Other Income | 19.48 | 28.24 | 2.33 | 2.32 | 3.11 | 2.43 |
| Stock Adjustments | 32.04 | 14.70 | -6.55 | 26.30 | 12.13 | 8.05 |
| Total Income | 1,569.71 | 1,833.75 | 1,662.47 | 1,568.34 | 1,255.54 | 1,116.47 |
| EXPENDITURE : | ||||||
| Raw Materials | 475.72 | 561.15 | 514.74 | 483.05 | 366.20 | 338.48 |
| Power and Fuel Cost | 53.45 | 55.31 | 50.61 | 42.78 | 36.89 | 34.75 |
| Employee Cost | 368.74 | 350.55 | 321.15 | 294.95 | 272.88 | 255.32 |
| Other Manufacturing Expenses | 91.60 | 116.72 | 89.70 | 60.66 | 46.07 | 44.38 |
| Selling and Administration Expenses | 387.49 | 407.12 | 340.26 | 293.42 | 258.53 | 287.83 |
| Miscellaneous Expenses | 45.19 | 64.86 | 58.79 | 64.15 | 48.29 | 29.95 |
| Employee Benefit Expenses | 368.74 | 350.55 | 321.15 | 294.95 | 272.88 | 255.32 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1,422.19 | 1,555.72 | 1,375.25 | 1,239.02 | 1,028.86 | 990.70 |
| Operating Profit | 147.50 | 278.02 | 287.22 | 329.32 | 226.69 | 125.77 |
| Interest | 56.63 | 36.81 | 25.03 | 14.14 | 22.22 | 26.25 |
| Gross Profit | 90.87 | 241.21 | 262.19 | 315.18 | 204.47 | 99.52 |
| Depreciation | 98.25 | 87.98 | 70.60 | 78.95 | 73.12 | 70.81 |
| Profit Before Tax | -7.38 | 153.23 | 191.59 | 236.23 | 131.35 | 28.71 |
| Current Tax | 0.00 | 32.77 | 55.20 | 93.23 | 38.47 | 3.86 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.36 | 3.81 | -4.97 | -11.52 | 0.48 | 0.60 |
| Reported Net Profit | -8.74 | 116.64 | 141.36 | 154.52 | 92.39 | 24.25 |
| Extraordinary Items | 1.15 | 8.49 | -0.90 | -0.31 | -0.17 | -0.19 |
| Adjusted Net Profit | -9.89 | 108.15 | 142.26 | 154.83 | 92.56 | 24.44 |
| Adjustment below Net Profit | -4.49 | 0.04 | 1.44 | -5.33 | -0.86 | -2.41 |
| P & L Balance brought forward | 781.49 | 685.55 | 563.48 | 428.11 | 339.35 | 320.27 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 13.83 | 20.73 | 20.73 | 13.82 | 2.76 | 2.76 |
| P & L Balance carried down | 754.44 | 781.49 | 685.55 | 563.48 | 428.11 | 339.35 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 10.00 | 75.00 | 112.50 | 112.50 | 75.00 | 15.00 |
| Dividend Per Share(Rs) | 0.20 | 1.50 | 2.25 | 2.25 | 1.50 | 0.30 |
| Earnings Per Share-Unit Curr | -0.95 | 12.65 | 15.34 | 16.77 | 10.03 | 2.63 |
| Earnings Per Share(Adj)-Unit Curr | -0.95 | 12.65 | 15.34 | 16.77 | 10.03 | 2.63 |
| Book Value | 119.61 | 122.22 | 111.45 | 98.13 | 83.44 | 73.81 |
| Book Value(Adj)-Unit Curr | 119.61 | 122.22 | 111.45 | 98.13 | 83.44 | 73.81 |
